EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-SA 4.0

Low-Dose Colchicine for Secondary Prevention of Cardiovascular Events in Coronary Artery Disease: A Systematic Review of Randomized Controlled Trials

Isral Masri, Indah Fitriani

Prima Journal of Medical Sciences · 30.09.2026 · 1 (2) · 110-115

DOI: 10.35730/tx7xer10 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Prima Journal of Medical Sciences, online erschienen am 30.09.2026. Verfasst von Isral Masri und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with coronary artery disease remain at risk of recurrent cardiovascular events despite standard therapy. Low-dose colchicine, an anti-inflammatory drug, has been tested in large randomized controlled trials (RCTs). This systematic review summarizes its efficacy and safety for secondary prevention.

Methods

Placebo-controlled RCTs of low-dose colchicine in adults with coronary artery disease or recent myocardial infarction, reporting a composite of major cardiovascular events, were eligible. Data were extracted and synthesized without meta-analysis following the SWiM reporting guideline, with qualitative risk-of-bias appraisal using RoB 2 domains.

Findings

Three RCTs (COLCOT, LoDoCo2, CLEAR; 17,329 randomized participants) were included. Colchicine 0.5 mg reduced the primary composite outcome in COLCOT (HR 0.77, 95% CI 0.61–0.96) and LoDoCo2 (HR 0.69, 95% CI 0.57–0.83), but not in CLEAR (HR 0.99, 95% CI 0.85–1.16). Diarrhea was more frequent with colchicine in CLEAR (10.2% vs 6.6%), serious pneumonia was more frequent in COLCOT (0.9% vs 0.4%), and non-cardiovascular death was numerically higher in LoDoCo2 (HR 1.51, 95% CI 0.99–2.31).

Conclusion

Evidence for colchicine in secondary prevention is inconsistent: two trials showed benefit and the largest trial showed none. Routine use cannot be supported on this evidence alone.

Zitieren

APA

Masri, I., & Fitriani, I. (2026). Low-Dose Colchicine for Secondary Prevention of Cardiovascular Events in Coronary Artery Disease: A Systematic Review of Randomized Controlled Trials. Prima Journal of Medical Sciences, 1(2), 110-115. https://doi.org/10.35730/tx7xer10

Vancouver

Masri I, Fitriani I. Low-Dose Colchicine for Secondary Prevention of Cardiovascular Events in Coronary Artery Disease: A Systematic Review of Randomized Controlled Trials. Prima Journal of Medical Sciences. 2026;1(2):110-115. doi:10.35730/tx7xer10

BibTeX
@article{Masri2026,
  author = {Masri, Isral and Fitriani, Indah},
  title = {Low-Dose Colchicine for Secondary Prevention of Cardiovascular Events in Coronary Artery Disease: A Systematic Review of Randomized Controlled Trials},
  journal = {Prima Journal of Medical Sciences},
  year = {2026},
  volume = {1},
  number = {2},
  pages = {110--115},
  doi = {10.35730/tx7xer10}
}
Kostenlos starten →